A Lone Voice Raises Alarms on Lucrative Diabetes Drugs
Dr. Peter C. Butler initially declined a request by the drug maker Merck to test whether its new diabetes drug, Januvia, could help stave off the disease in rats.
“I said, I’m not interested in your money, go away,” Dr. Butler recalled.
Merck no doubt now wishes it had. When Dr. Butler finally agreed to do the study, he found worrisome changes in the pancreases of the rats that could lead to pancreatic cancer. Read more
Latest posts by Sripathi R. Kethu, M.D. FACG. (see all)
- Adolescents Living With Diabetes - August 6, 2022
- Diabetes Insipidus Symptoms, Causes, & Prevention - July 26, 2022
- Insulin Shortage May Affect Almost Half of the Diabetics by 2030 - November 24, 2018
Pingback: Melissa Tower (melissatower) | Pearltrees